Prime Minister Fredrik Reinfeldt opens Gamma Knife Center Santiago

The Gamma Knife Center in Santiago, Chile, was opened by Prime Minister Fredrik Reinfeldt at the end of May. Swedfund is one of the organisations involved in Gamma Knife Center – through the project development company Global Medical Investments (GMI) AB. EKN has issued a guarantee to the financier of the project.

For more information visit here

Stereotactic radiosurgery of essential trigeminal neuralgia using Leksell Gamma Knife model C with automatic positioning system

In conclusion, radiosurgery of essential trigeminal neuralgia results in a high rate of initial pain relief, but pain recurrences and associated complications are not uncommon. The outcome may be influenced by various technical nuances; therefore, treatment should be preferably done in specialized clinical centers with sufficient expertise in the management of this disorder.


For more information visit here

Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy


ATLANTAJune 24, 2011 /PRNewswire/ -- Elekta's Leksell Gamma Knife® Perfexion™ earned the number one ranking in the KLAS research firm's recently released 2011 Top 20 Best in KLAS Awards: Medical Equipment & Infrastructure* report. Perfexion received Best in KLAS in the radiation therapy category.
In the report, Perfexion scored 92.9 out of 100 and 95 percent of customers indicated they would buy again. On a 1 to 9 scale, Perfexion received an 8.6 from respondents for satisfaction with product uptime, the highest score among all vendors rated in the market segment.
"Leksell Gamma Knife has been the gold standard for radiosurgery for many years," says Jay Hoey, Executive Vice President, Elekta North America. "Our latest generation solution, Perfexion, was designed and developed based on the insight of expert Leksell Gamma Knife users. The Best in KLAS designation recognizes not only the sophistication of this radiosurgery platform, but also the contributions of our clinical partners in making it a reality."
Elekta posted record-breaking sales of Leksell Gamma Knife systems in 2010, confirming the growing demand for the system as a safe, effective modality to treat brain metastases and other cranial disorders.
Gamma Knife® surgery is a gentler alternative to traditional brain surgery for illnesses such as metastatic disease – cancer that has traveled to the brain from elsewhere in the body. The system precisely delivers up to thousands of low-intensity radiation beams to one or more targets in a single session. Leksell Gamma Knife Perfexion provides even greater speed and ease of use than previous versions, especially for treating multiple metastases.
Supported by three decades of clinical practice in both neurosurgery and radiation oncology departments, more than 50,000 patients each year are treated with Gamma Knife surgery.
KLAS gathers opinions of thousands of healthcare professionals
The KLAS awards are based on data from customer surveys of hospital and clinic executives, administrators, physicians, nurses and other directors and managers interacting with healthcare equipment and infrastructure solutions.
According to KLAS, Best in KLAS designations go to solutions that have excelled in their respective market segments, that show the vendor's leadership in working with customers to resolve issues and match expectations to reality, and that have the broadest operational and clinical impact to healthcare organizations.
"Best in KLAS recognition – which indicates leadership in working with customers to resolve issues and match needs to delivered solutions – is awarded to healthcare vendors who have consistently excelled in their market segment(s)," says Adam Gale, president of KLAS. "We are pleased that the healthcare industry recognizes the value of the 'Best in KLAS' award. The awards in this report help put the aggregate perceptions and opinions of healthcare executives and clinicians into perspective – especially as their peers consider major investment decisions."
The 2011 Top 20 Best in KLAS Awards: Medical Equipment & Infrastructure report is available online. To purchase the full report, visit www.KLASresearch.com/BestinKLAS.
*2011 Top 20 Best in KLAS Awards: Medical Equipment & Infrastructure," June, 2011. © 2011 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located inStockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.

Source : PR Newswire
Source : 

Leeds Gamma Knife Centre supports Symposium on Aspects of Gamma Knife Radiosurgery

Lead neurosurgeon, Mr Nick Philips, lead consultant clinical oncologist, Dr Paul Hatfield, and nurse manager Kate Casey of the Leeds Gamma Knife Centre are set to support the advancement of Gamma Knife radiosurgery with their attendance at the 5th Annual Radiosurgery Symposium at St Bartholomew’s Hospital on Friday 2nd Sept 2011.


For more information, go to: Symposium on Aspects of Gamma Knife Radiosurgery

Gamma Knife System Supplied by American Shared Hospital Services Begins Treating Patients at Baskent University in Turkey


AMERICAN SHARED HOSPITAL SERVICES (NYSE AMEX:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that the Gamma Knife® system it supplied to Baskent University, Adana, Turkey under a contract announced in March 2011 has begun treating patients, including 11 patients treated in just the first week of clinical operations–the highest start-up volume of any Gamma Knife in AMS' 20-year history. The Kisla Campus of Baskent University houses the largest and most modern oncology center in the Adana region, now including both a Gamma Knife and two linear accelerator devices used for radiation therapy. Baskent University has a total of 561 hospital beds.
AMS Chairman and Chief Executive Officer Ernest A. Bates, M.D., said, "Turkey is the fastest growing economy in Europe and the third fastest growing economy in the world behind only China and India. Given the small number of radiosurgery devices and services in the country today, and the fact that more than 90% of the population of 77 million is covered by health insurance, Turkey represents a significant growth opportunity for AMS. Together with our partner EMKA LLC, an affiliate of Ankara-based ÖZYÜREK A.Ş., Elekta's distributor in Turkey for the past twenty five years, we are committed to pursuing this opportunity aggressively."
About Gamma Knife Surgery
Gamma Knife surgery, sometimes referred to as stereotactic radiosurgery (SRS), is a non-invasive method for treating brain disorders. It is the delivery of a single, high dose of radiation to a small and critically located intra-cranial volume through the intact skull. It is preferred for its extreme accuracy, efficiency and outstanding therapeutic response. Today, Gamma Knife surgery is performed in hundreds of leading hospitals and clinics around the world. Approximately 50,000 patients undergo Gamma Knife surgery every year, and this unique procedure has an impressive scientific track record with thousands of peer-reviewed articles. No other non-invasive treatment method in this field has greater clinical acceptance.
About AMS
American Shared Hospital Services (www.ashs.com) provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. Since 1991, AMS' creative financing solutions have enabled its clinical partners to make the latest advances in radiation oncology available to patients at an affordable price. AMS is the world leader in providing Gamma Knife Radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The Company also offers the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the 21st Century® concept. AMS also is a leader in proton beam radiation therapy (PBRT), the next great growth opportunity in radiation oncology. AMS currently is developing PBRT centers in Dayton, Ohio (Kettering Medical Center), Boston (Tufts Medical Center), Orlando (Orlando Regional Healthcare) and Long Beach, California (Long Beach Memorial Medical Center), and is negotiating additional projects. AMS also owns a preferred stock investment in Still River Systems, developer of the compact Monarch 250 PBRT system, which has not yet been approved by the FDA.
Safe Harbor Statement
This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services, which involve risks and uncertainties including, but not limited to, the risks of the Gamma Knife and radiation therapy businesses, the risks of developing The Operating Room for the 21st Century program, and the risks of investing in a development-stage company, Still River Systems, Inc., without a proven product.Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2010, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, and the definitive Proxy Statement for the Annual Meeting of Shareholders held on June 9, 2011.
Source : BusinessWire

Midland Welcomes 1000th Gamma Knife Patient

Gamma Knife® team at MidMichigan Medical Center–Midland treated their 1,000th patient. Less than 24 hours after being treated for a benign brain tumor. 

For details please visit link here

http://www.midmichigan.org/about/news/2009/Midland-Welcomes-1000th-Gamma-Knife-Patient/

If you have any query regarding Gamma Knife Radiosurgery you can contact us

There was an error in this gadget
gammaknifeinfo.blogspot.com is a web directory which guides you to find out websites related with all gamma knife centre, gamma knife hospital, journals, gamma knife lectures, gamma knife e books, gamma knife videos,gamma knife forums,...etc. To help others in gamma knife related website or link please contribute Email me .